SEARCH

SEARCH BY CITATION

References

  • Arias LF, Blanco J, Sanchez-Fructuoso A, Prats D, Duque E, Sáiz-Pardo M, Ruiz J, Barrientos A (2007) Histologic assessment of donor kidneys and graft outcome: multivariate analyses. Transplant. Proc. 39, 13681370.
  • Beausejour CM, Krtolica A, Galimi F et al . (2003) Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22, 42124222.
  • Ben-Porath I, Weinberg RA (2004) When cells get stressed: an integrative view of cellular senescence. J. Clin. Invest. 113, 813.
  • Campisi J (1996) Replicative senescence: an old lives’ tale? Cell 84, 497500.
  • Cawthon RM (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res. 30, e47.
  • Cohen B, Smits JM, Haase B, Persijn G, Vanrenterghem Y, Frei U (2005) Expanding the donor pool to increase renal transplantation. Nephrol. Dial Transplant 20, 3441.
  • Dominguez J, Kompatzki A, Velasco A, Turpaud F, Norambuena R, Arenas J, Pais E, Llanos R, Cortez-Monroy G (2005) Importance of early adequate exposure to cyclosporine in renal transplant outcome: study of 1-year creatinine. Transplant. Proc. 37, 33583360.
  • Edwards MG, Anderson RM, Yuan M, Kendziorski CM, Weindruch R, Prolla TA (2007) Gene expression profiling of aging reveals activation of a p53 mediated transcriptional program. BMC Genomics 23, 80.
  • Epel ES, Blackburn EH, Lin J, Dhabbhar FS, Adler NE, Morrow JD, Cawthon RM (2004) Accelerated telomere shortening in response to life stress. Proc. Natl Acad. Sci. USA 101, 1731217315.
  • Ferlicot S, Durrbach A, Ba N, Desvaux D, Bedossa P, Paradis V (2003) The role of replicative senescence in chronic allograft nephropathy. Hum. Pathol. 34, 924928.
  • Frei U, Noeldeke J, Machold-Fabrizii V, Arbogast H, Margreiter R, Fricke L, Voiculescu A, Kliem V, Ebel H, Albert U, Lopau K, Schnuelle P, Nonnast-Daniel B, Pietruck F, Offermann R, Persijn G, Bernasconi C (2008) Prospective age matching in elderly kidney transplant recipients – a 5-year analysis of the Eurotransplant Senior Program. Am. J. Transplant. 8, 5057.
  • Gjertson DW (2004) Explainable variation in renal transplant outcomes: a comparison of standard and expanded criteria donors. Clin. Transpl. 30314.
  • Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585621.
  • Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM (2004) Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell 14, 501513.
  • Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, Dombkowski DM, Cheng T, DePinho RA, Sharpless NE, Scadden DT (2006) Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443, 421426.
  • Jennings P, Koppelstaetter C, Aydin S, Abberger T, Wolf AM, Mayer G, Pfaller W (2007) Cyclosporine A induces senescence in renal tubular epithelial cells. Am. J. Physiol. Renal. Physiol. 293, F831F838.
  • Joosten SA, Van Ham V, Nolan CE, Borrias MC, Jardine AG, Shiels PG, Van Kooten C, Paul LC (2003) Telomere shortening and cellular senescence in a model of chronic renal allograft rejection. Am. J. Pathol. 162, 13051312.
  • Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, Sharpless NE (2004) Ink4a/Arf expression is a biomarker of aging. Clin. Invest 114, 12991307.
  • Lee CM, Scandling JD, Shen GK, Salvatierra O, Dafoe DC, Alfrey EJ (1996) The kidneys that nobody wanted. Support for the utilization of expanded criteria donors. Transplantation 62, 18321841.
  • Lloyd AC (2002) Limits to lifespan. Nat. Cell Biol. 4, E25E27.
  • Mayer G, Persijn GG (2006) Eurotransplant kidney allocation system (ETKAS): rationale and implementation. Nephrol. Dial Transplant 21, 23.
  • Melk A, Ramassar V, Helms LM, Moore R, Rayner D, Solez K, Halloran PF (2000) Telomere shortening in kidneys with age. J. Am. Soc. Nephrol. 11, 444453.
  • Melk A, Schmidt BM, Takeuchi O, Sawitzki B, Rayner DC, Halloran PF (2004) Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int. 65, 510520.
  • Melk A, Schmidt BM, Vongwiwatana A, Rayner DC, Halloran PF (2005) Increased expression of senescence-associated cell cycle inhibitor p16INK4a in deteriorating renal transplants and diseased native kidney. Am. J. Transplant 5, 13751382.
  • Molofsky AV, Slutsky SG, Joseph NM, He S, Pardal R, Krishnamurthy J, Sharpless NE, Morrison SJ (2006) Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443, 448452.
  • Morris PJ, Johnson RJ, Fuggle SV, Belger MA, Briggs JD (1999) Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA). Lancet 354, 11471152.
  • Okuda K, Bardeguez A, Gardner JP, Rodriguez P, Ganesh V, Kimura M, Skurnick J, Awad G, Aviv A (2002) Telomere length in the newborn. Pediatr. Res. 52, 377381.
  • Oppenheimer F, Aljama P, Asensio Peinado C, Bustamante Bustamante J, Crespo Albiach JF, Guirado Perich L (2004) The impact of donor age on the results of renal transplantation. Nephrol. Dial. Transplant. 19(Suppl. 3), iii1115.
  • Prommool S, Jhangri GS, Cockfield SM, Halloran PF (2000) Time dependency of factors affecting renal allograft survival. J. Am. Soc. Nephrol. 11, 565573.
  • Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y (1999) The Banff 97 working classification of renal allograft pathology. Kidney Int. 55, 713723.
  • Shay JW, Wright WE (2000) Hayflick, his limit, and cellular aging. Nat. Rev. Mol. Cell Biol. 1, 7276.
  • Siddiqi N, McBride MA, Hariharan S (2004) Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis. Kidney Int. 65, 19061913.
  • Sis B, Tasanarong A, Khoshjou F, Dadras F, Solez K, Halloran PF (2007) Accelerated expression of senescence associated cell cycle inhibitor p16INK4A in kidneys with glomerular disease. Kidney Int. 71, 218226.
  • Smits JM, Persijn GG, Van Houwelingen HC, Claas FH, Frei U (2002) Evaluation of the Eurotransplant Senior Program. The results of the first year. Am. J. Transplant 2, 664670.
  • Stengel B, Billon S, Van Dijk PC, Jager KJ, Dekker FW, Simpson K, Briggs JD (2003) Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990–1999. Nephrol. Dial Transplant. 18, 18241833.
  • Tanaka T, Kyo M, Kokado Y, Takahara S, Hatori M, Suzuki K, Hasumi M, Toki K, Ichimaru N, Yazawa K, Hanafusa T, Namba Y, Oka K, Moriyama T, Imai E, Okuyama A, Yamanaka H (2004) Correlation between the Banff 97 classification of renal allograft biopsies and clinical outcome. Transpl. Int. 17, 5964.
  • USRDS (2004) Incidence and prevalence of ESRD. Annual Data Report 5870. Minneapolis: USRDS.
  • Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med. 341, 17251730.
  • Zindy F, Quelle DE, Roussel MF, Sherr CJ (1997) Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15, 203211.